News

Shares in Summit Therapeutics have risen sharply on a report that AstraZeneca is in discussions for a partnership focused on ...
IMM2510, a differentiated PD-L1xVEGF bispecific antibody with upcoming data in H2 2025. Click to read why TIL is a Hold.
Shares of this biotech giant have lost 16.3% year to date compared with the industry’s decline of 2.7%. The sto ...
Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...
CVAC jumps 41% in a month after signing a $1.25B deal to be acquired by BioNTech to accelerate mRNA therapy development.
Meanwhile, Nova One Advisor projects the global oncology drug market will climb to US$366.24 billion by 2034, expanding at a ...
Jo Hyun-kyun resigns from The Boyz amid prostitution allegations and agency response Member Jo Hyun-kyun of the group The Boyz shocked fans by announ ...
Asembia’s AXS25 Summit—held annually at both the Wynn and Encore in Las Vegas, NV—brings together thousands of pharmaceutical industry executives in hopes of continuing the conversation surrounding ...
Verve Therapeutics VERV signed a definitive agreement with pharma bigwig Eli Lilly LLY. Per the terms, the pharma giant will acquire all outstanding shares of VERV for $10.50 per share in cash ...